Stocks to sell

Excitement stemming from possible U.S. pot reform has dissipated and Canopy Growth (CGC) stock is again moving lower. While better positioned to capitalize on pot reform than peers, other issues will likely push it to lower prices. Much like how you should “just say no” to Hexo (HEXO), the same applies here with Canopy. Source:

New Oriental Education & Technology Group (NYSE:EDU), a provider of private educational services in China, is watching its business collapse. This is due to regulation and China’s decision to crack down on its off-campus tutoring industry. Shares of New Oriental have losses of nearly 50% in 2022 and are down approximately 92.9% in the past

AMC Entertainment (NYSE:AMC) recently announced that it acquired seven locations with 66 screens in Connecticut, Upstate New York and Annapolis, Maryland. The meme-friendly theatre chain acquired the theatres from Bow Tie Cinemas. AMC stock gained 6% on the news.  While the stock got a one-day boost from the news, the acquisition of these theatres will

Camber Energy (NYSE:CEI) has not filed its 2021 financials and has until May 20 to do so according to a recent filing. But this has not stopped the company from making a series of acquisitions that have pumped up CEI stock. Camber’s main subsidiary has announced the acquisition of a renewable diesel production over the

Rivian (RIVN) is facing macroeconomic and geopolitical headwinds The IPO lock-up expires in May, allowing early investors to sell their shares Investors should stay away from RIVN stock until further updates are provided on fundamentals Source: Miro Vrlik Photography / Shutterstock.com Rivian’s (NASDAQ:RIVN) fall from grace is a hard pill to swallow for its investors.

Tilray (NASDAQ:TLRY) announced on April 6 that its quarterly earnings ending Feb. 28 finally turned net income profitable. That’s the good news for the No. 1 market share cannabis company in Canada. But it also has bad news, hidden in the details that could keep hurting TLRY stock. So Tilray merged with Aphria last year

Bed Bath & Beyond (BBBY) just got three seats on its board. GameStop (GME) savior Ryan Cohen ought to pick one or the other. The smart move for investors is not to own either. Most investors following GameStop (NYSE:GME) know that Ryan Cohen, the so-called savior of the video game retailer, owns 11.9% of GME

Home Point Capital (HMPT): Market realities may end up hurting this residential mortgage originator. Caci (CACI): Not every defense firm may benefit from the Ukraine conflict due to necessary restraint. CarMax (KMX): The used-car market might be getting too rich for investors’ blood. JetBlue Airways (JBLU): A proposed buyout makes many analysts nervous about JBLU

When it comes to Restoration Hardware (RH), there’s a lot of attention on its plans to split its shares on a 3-to-1 basis. You may think this is a potential catalyst, but factors more pertinent to the underlying company outweigh it. Even as slowing growth appears priced-in, more disappointment could send it to even lower

Camber Energy (CEI) says it’s a carbon capture play It’s a failing oil driller, backed by tweets and a short squeeze Please don’t buy it unless you like to lose money Source: OlegRi / Shutterstock Camber Energy (NYSEAMERICAN:CEI) stock is not and likely never will be an investment. It’s a dream, backed by stock, that

Novavax (NASDAQ:NVAX) stock has seen a big plunge from all-time highs of $277. The downtrend seems unabated with NVAX stock trading almost 6% lower in today’s trade. A surge in cases related to omicron subvariant BA.2 is an indication of the point that the pandemic is far from over. However, NVAX stock has not responded

Tesla’s (NASDAQ:TSLA) Austin gigafactory Factory will benefit stock prices. But Tesla’s most productive factory now sits idle due to Covid-19 precautions. Hawkish news out of the Federal Reserve doesn’t benefit growth plays including Tesla. Source: Grisha Bruev / Shutterstock.com Tesla (NASDAQ:TSLA) is battling a lot of production issues currently. As a result, the stock could

Newegg (NASDAQ:NEGG) stock has important strengths and key weaknesses. Newegg — an e-commerce company that focuses on tech — is a profitable, rapidly growing company in an expanding, very promising sector. But on the other hand, it appears to be a meme stock and has become linked to cryptocurrencies at a time when meme stocks

Biogen’s (BIIB) Aduhelm looks like a market failure Approvals on treatments that don’t cure are now under challenge There can be no unlimited draw from a limited pool of funds Source: PictureDesignSwiss / Shutterstock.com When Biogen (NASDAQ:BIIB) stock got its Alzheimer’s drug Aduhelm approved last June, the stock spiked to nearly $420/share. It was due

Genius Group (NYSEMKT:GNS) launched out of the gate with an incredible blast Tuesday. GNS stock exploded 408% higher on its first day of trading as a public company. This is quite the surprise, as Genius is not a well-established company. The offering’s lead underwriter, Boustead Securities, is not a top-tier initial public offering (IPO) shop.

Today’s price action in the broader market is certainly something most investors don’t want to see. The three major indices are solid red, with most major growth stocks getting hit hard today. Investors in SoFi Technologies (NASDAQ:SOFI) and SOFI stock have not been spared. In fact, SOFI stock hit a fresh new 52-week low today, trading as low

PayPal (PYPL) investors are undoubtedly seeking relief after the company’s disappointing financial report. Yet, that relief is unlikely to come as PayPal will have to deal with a potentially turbulent cryptocurrency market. Investors should sidestep these tricky issues by simply refraining from buying shares of PayPal. Source: Michael Vi / Shutterstock.com It’s no secret that

Elon Musk sent Twitter (TWTR) stock up 20%, buying 9.2% and joining the board. Twitter has been trying to collect cash from users for months, with limited success. Fundamentals say sell. Source: Worawee Meepian / Shutterstock.com Elon Musk sent Twitter (NYSE:TWTR) stock up by about 25% by the end of April 2 by buying 9.2%

Novavax (NASDAQ:NVAX) and other vaccine makers are dropping in anticipation of an advisory panel meeting of the U.S. Food and Drug Administration (FDA) regarding booster shots. This is a panel meeting of outside experts. The topic? To whom and when should a second round of covid-19 booster shots be administered to. The FDA already authorized

So far this year, Disney (NYSE:DIS) stock is down 15%. The market is not pleased with its earnings, negative free cash flow and huge spending on content. That has spilled over to the poor returns for DIS stock. For example, in its fiscal Q1 report for the quarter ending Jan. 1, made $1.15 billion in